Death in China's brain-targeted gene-editing trial ignites ethics debate amid biotech surge
TL;DR
A young girl died in an experimental brain-targeted gene-editing trial at Shanghai Jiaotong University, prompting an ethics investigation and highlighting gaps in oversight amid China's booming biotech sector; authorities have since tightened rules around investigator-initiated trials and reporting of adverse events, but observers warn that more safeguards are needed to prevent recurring ethical lapses.
- Girl’s undisclosed death in gene-editing trial raises red flags in booming Chinese industry CNN
- In China, the hidden death of 'Mei', a 6-year-old girl, after gene therapy raises many questions Le Monde.fr
- 6-year-old girl dies after parents paid $860K for experimental therapy that ‘shouldn’t have gone to trial’ nypost.com
- China biotech sector fears policy backlash after girl dies in gene-editing trial South China Morning Post
- Scandal Exposes Limits of China’s Scientific Rise foreignpolicy.com
Want the full story? Read the original reporting
Read on CNN